Pages that link to "Q48491146"
Jump to navigation
Jump to search
The following pages link to Glucocerebrosidase mutations are an important risk factor for Lewy body disorders (Q48491146):
Displaying 50 items.
- Parkinson's disease: from monogenic forms to genetic susceptibility factors (Q22242870) (← links)
- Gaucher disease glucocerebrosidase and α-synuclein form a bidirectional pathogenic loop in synucleinopathies (Q24307627) (← links)
- Glucocerebrosidase is shaking up the synucleinopathies (Q24337392) (← links)
- Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. (Q24634577) (← links)
- Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease (Q24656668) (← links)
- Catecholamine autotoxicity. Implications for pharmacology and therapeutics of Parkinson disease and related disorders (Q26826093) (← links)
- Glia and alpha-synuclein in neurodegeneration: A complex interaction (Q26851153) (← links)
- Gaucher disease and comorbidities: B-cell malignancy and parkinsonism (Q27002301) (← links)
- Glucocerebrosidase and Parkinson disease: Recent advances (Q27005669) (← links)
- Structure of acid beta-glucosidase with pharmacological chaperone provides insight into Gaucher disease (Q27643401) (← links)
- Neuroinflammation and α-synuclein accumulation in response to glucocerebrosidase deficiency are accompanied by synaptic dysfunction (Q28512774) (← links)
- Cognitive and Antipsychotic Medication Use in Monoallelic GBA-Related Parkinson Disease (Q30409165) (← links)
- Glucocerebrosidase mutations in Chinese subjects from Taiwan with sporadic Parkinson disease (Q30483458) (← links)
- GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology (Q30527838) (← links)
- Clinical and biochemical differences in patients having Parkinson disease with vs without GBA mutations. (Q30544056) (← links)
- Glucocerebrosidase mutations in 108 neuropathologically confirmed cases of multiple system atrophy (Q33668478) (← links)
- Glucocerebrosidase gene mutations: a risk factor for Lewy body disorders (Q33677320) (← links)
- Parkin-mediated ubiquitination of mutant glucocerebrosidase leads to competition with its substrates PARIS and ARTS (Q33818612) (← links)
- Lysosomal function in macromolecular homeostasis and bioenergetics in Parkinson's disease (Q33843073) (← links)
- Multiple pathogenic proteins implicated in neuronopathic Gaucher disease mice (Q33847578) (← links)
- A novel locus for dementia with Lewy bodies: a clinically and genetically heterogeneous disorder (Q34005558) (← links)
- Gaucher disease ascertained through a Parkinson's center: imaging and clinical characterization (Q34037141) (← links)
- Gaucher disease: insights from a rare Mendelian disorder (Q34077331) (← links)
- The link between the GBA gene and parkinsonism (Q34077492) (← links)
- Glucosidase-beta variations and Lewy body disorders (Q34267687) (← links)
- Glucocerebrosidase mutations in primary parkinsonism (Q34491177) (← links)
- Phenotype, diagnosis, and treatment of Gaucher's disease (Q34907714) (← links)
- The neurogenetics of atypical parkinsonian disorders (Q35008908) (← links)
- Bridging molecular genetics and biomarkers in lewy body and related disorders (Q35094391) (← links)
- CNS expression of glucocerebrosidase corrects alpha-synuclein pathology and memory in a mouse model of Gaucher-related synucleinopathy (Q35122963) (← links)
- Alpha-synuclein interacts with Glucocerebrosidase providing a molecular link between Parkinson and Gaucher diseases (Q35150090) (← links)
- Genetic players in multiple system atrophy: unfolding the nature of the beast (Q35169246) (← links)
- Exploring the link between glucocerebrosidase mutations and parkinsonism (Q35955350) (← links)
- Glucocerebrosidase is present in α-synuclein inclusions in Lewy body disorders (Q35960413) (← links)
- Glucocerebrosidase Deficiency in Drosophila Results in α-Synuclein-Independent Protein Aggregation and Neurodegeneration (Q35971649) (← links)
- Deficient vesicular storage: A common theme in catecholaminergic neurodegeneration. (Q36011221) (← links)
- Strikingly different clinicopathological phenotypes determined by progranulin-mutation dosage (Q36017101) (← links)
- Genome-wide association study of neocortical Lewy-related pathology (Q36072427) (← links)
- GBA mutations are associated with Rapid Eye Movement Sleep Behavior Disorder (Q36072435) (← links)
- The cognitive profile of type 1 Gaucher disease patients (Q36315252) (← links)
- Glucocerebrosidase mutations alter the endoplasmic reticulum and lysosomes in Lewy body disease (Q36389683) (← links)
- The role of glucocerebrosidase mutations in Parkinson disease and Lewy body disorders (Q36486264) (← links)
- Glucocerebrosidase mutations in diffuse Lewy body disease (Q36487922) (← links)
- Transcranial sonography and functional imaging in glucocerebrosidase mutation Parkinson disease (Q36595145) (← links)
- ER Stress and Autophagic Perturbations Lead to Elevated Extracellular α-Synuclein in GBA-N370S Parkinson's iPSC-Derived Dopamine Neurons. (Q36678823) (← links)
- Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease (Q36761674) (← links)
- Genetics of Parkinson disease (Q37037053) (← links)
- The spectrum of parkinsonian manifestations associated with glucocerebrosidase mutations (Q37068884) (← links)
- Progress in the pathogenesis and genetics of Parkinson's disease (Q37143657) (← links)
- Mutations in GBA are associated with familial Parkinson disease susceptibility and age at onset (Q37180477) (← links)